1、 https:/crsreports.congress.gov Updated August 5, 2021Global COVID-19 Vaccine Distribution Background The Coronavirus Disease 2019 (COVID-19) pandemic has led to severe health and economic consequences across the globe, as governments work to contain the spread of the virus and its variants. In late
2、 2020, researchers started identifying several COVID-19 variants, now driving surges in related cases and deaths across Africa and south Asia. The United States, India, and Brazil have the highest number of confirmed COVID-19 cases, many caused by the Delta variant. Vaccines and other countermeasure
3、s play a growing role in COVID-19 control. However, insufficient access to vaccines in many low- and middle-income countries (LMICs) raises questions about how inequities may hinder pandemic control worldwide. Congress appropriated approximately $15 billion for a range of COVID-19-related responses
4、through supplemental appropriations (P.L. 116-123, P.L. 116-136, P.L. 116-260, and P.L. 117-2), including $4 billion for multilateral COVID-19 vaccine efforts. The Biden Administration has announced that the United States will provide over 500 million vaccine doses worldwide through direct donations